Showing results (81-90 of 137) with videos related to
Sort By:
Pageof 14
Anti-Cancer Agents in Medicinal Chemistry|January 24, 2012
Anticancer effects of the organosilicon multidrug resistance modulator SILA 421Ulrike Olszewski, Robert Zeillinger, Meltem Demirel Kars, et al.Expert Review of Vaccines|November 8, 2013
Introducing new vaccines in developing countriesSonali Kochhar, Barbara Rath, Lea D Seeber, et al.The Journal of Applied Laboratory Medicine|July 20, 2022
Summarizing Study Characteristics and Diagnostic Performance of Commercially Available Tests for Respiratory Syncytial Virus: A Scoping Literature Review in the COVID-19 EraDavid I Bernstein, Asuncion Mejias, Barbara Rath, et al.Wiener Klinische Wochenschrift|April 15, 2025
Markers for the angiogenic potential of fat graftsMaryana Teufelsbauer, Sandra Stickler, Marie-Therese Eggerstorfer, et al.Clinical Pharmacology : Advances and Applications|February 1, 2012
In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compoundsUlrike Olszewski, Thomas Tuxen Poulsen, Ernst Ulsperger, et al.Metal-Based Drugs|July 10, 2009
In Vitro Evaluation of Oxoplatin: An Oral Platinum(IV) Anticancer AgentUlrike Olszewski, Florian Ach, Ernst Ulsperger, et al.Current Drug Safety|April 11, 2015
Controlled language and information on vaccines: application to package insertsJulie Renahy, Dominique A Vuitton, Barbara Rath, et al.Investigational New Drugs|February 18, 2010
Anticancer activity and mode of action of titanocene CUlrike Olszewski, James Claffey, Megan Hogan, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 4, 2009
Circulating cytokeratin 18 fragment m65-a potential marker of malignancy in colorectal cancer patientsChristoph Ausch, Veronika Buxhofer-Ausch, Ulrike Olszewski, et al.Scientific Reports|January 22, 2025
Characterization of a pleomorphic rhabdomyosarcoma cell lineSandra Stickler, Clemens Lang, Maximilian Rieche, et al.Pageof 14